A novel brief treatment for methamphetamine use disorders in South Africa: a randomised feasibility trial.
CONCLUSIONS: This feasibility trial suggests that the locally adapted IDMI intervention is an acceptable and safe intervention as a brief treatment for MAUD in South Africa. Modifications to the study design should be considered in a fully powered, definitive controlled trial to assess this potentially effective intervention. Trial registration The trial is registered with the Pan African Clinical Trials Registry (Trial ID: PACTR201310000589295).
PMID: 33413631 [PubMed - in process]
Source: Addiction Science and Clinical Practice - Category: Addiction Authors: Sorsdahl K, Stein DJ, Pasche S, Jacobs Y, Kader R, Odlaug B, Richter S, Myers B, Grant JE Tags: Addict Sci Clin Pract Source Type: research
More News: Addiction | African Health | Clinical Trials | Grants | Methamphetamine | Psychology | Science | South Africa Health | Study